Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Mereo BioPharma Group plc (MREO)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.4300+0.0300 (+2.14%)
At close: 04:00PM EST
1.4700 +0.04 (+2.80%)
After hours: 05:48PM EST
Advertisement
Advertisement
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

Currency in GBP. All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
Total Revenue
36,464
0
0
0
Cost of Revenue
34,484
16,347
23,608
22,704
Gross Profit
1,980
-16,347
-23,608
-22,704
Operating Expense
23,062
21,222
15,909
12,505
Operating Income
-21,082
-37,569
-39,517
-35,208
Net Non Operating Interest Income Expense
-5,440
-6,339
-3,575
-2,032
Other Income Expense
-2,923
-122,542
1,974
-65.766
Pretax Income
-29,445
-166,450
-41,118
-37,306
Tax Provision
-2,524
-2,822
-6,274
-5,277
Net Income Common Stockholders
-26,921
-163,628
-34,844
-32,029
Diluted NI Available to Com Stockholders
-26,921
-163,628
-34,844
-32,029
Basic EPS
-
-2.40
-1.95
-2.25
Diluted EPS
-
-2.40
-1.95
-2.25
Basic Average Shares
-
68,178
17,885
14,229
Diluted Average Shares
-
68,178
17,885
14,229
Total Operating Income as Reported
-21,082
-37,569
-39,517
-35,208
Rent Expense Supplemental
0
-
0
293.328
Total Expenses
57,546
37,569
39,517
35,208
Net Income from Continuing & Discontinued Operation
-26,921
-163,628
-34,844
-32,029
Normalized Income
-24,249
-43,164
-36,517
-31,972
Interest Income
-33
5
183
306.831
Interest Expense
5,428
6,383
4,827
3,055
Net Interest Income
-5,440
-6,339
-3,575
-2,032
EBIT
-24,017
-160,067
-36,291
-34,251
EBITDA
-23,176
-
-
-
Reconciled Cost of Revenue
34,484
16,347
23,608
22,704
Reconciled Depreciation
841
1,599
1,577
37.796
Net Income from Continuing Operation Net Minority Interest
-26,921
-163,628
-34,844
-32,029
Total Unusual Items Excluding Goodwill
-2,923
-122,542
1,974
-65.766
Total Unusual Items
-2,923
-122,542
1,974
-65.766
Normalized EBITDA
-20,253
-35,926
-36,688
-34,148
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
-250.557
-2,078
301.2033
-9.3034
Advertisement
Advertisement